Eisenman Launches Indiegogo Campaign with Germicidal Cordless UV-C Lamp
Eisenman, a group that runs a pediatric/OBGYN clinic in Tainan, announced their first Indiegogo campaign for the Eisenman Germicidal Cordless UV-C lamp. Paired with a dedicated mobile app, the UV-C lamp allows users to schedule and sanitize every corner of their home and office safely and effectively.
UV-C light can destroy the chemical bonds of genetic material (DNA/RNA). Pathogens either die immediately or lose their ability to produce proteins and reproduce—the result is instant disinfection. UV-C light has been proven to destroy common pathogens such as bacteria, viruses, and mold.
The Eisenman UV-C lamp is equipped with cold cathode lamps made by Stanley Electric, the world-renowned electric lights manufacturer from Japan, which offers over 50,000 hours of rated life. By using the 254-nanometre wavelength UV-C light, the lamp can instantly deactivate microorganisms.
It also features a 3000mAh built-in battery that provides up to 6 hours of independent operation. With the patented suction mount, users can attach the sanitizer to any flat surface, including a robot vacuum, to autonomously disinfect hard-to-reach surfaces.
UV-C light can destroy the chemical bonds of genetic material (DNA/RNA). Pathogens either die immediately or lose their ability to produce proteins and reproduce—the result is instant disinfection. UV-C light has been proven to destroy common pathogens such as bacteria, viruses, and mold.
The Eisenman UV-C lamp is equipped with cold cathode lamps made by Stanley Electric, the world-renowned electric lights manufacturer from Japan, which offers over 50,000 hours of rated life. By using the 254-nanometre wavelength UV-C light, the lamp can instantly deactivate microorganisms.
It also features a 3000mAh built-in battery that provides up to 6 hours of independent operation. With the patented suction mount, users can attach the sanitizer to any flat surface, including a robot vacuum, to autonomously disinfect hard-to-reach surfaces.
No comments: